|
| Press Releases |
|
 |
|
| Friday, September 23, 2022 |
|
|
Malaysian Genomics Grows Presence in Thailand |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
| Wednesday, September 21, 2022 |
|
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
| Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
| Tuesday, August 30, 2022 |
|
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
| Monday, August 29, 2022 |
|
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
| Thursday, August 18, 2022 |
|
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
| Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
| Wednesday, July 20, 2022 |
|
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
| UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
| Friday, July 15, 2022 |
|
|
Malaysian Genomics Appoints New Chairman |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
| Wednesday, July 13, 2022 |
|
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
| Friday, July 8, 2022 |
|
|
Malaysian Genomics Proposes Private Placement |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
| Wednesday, July 6, 2022 |
|
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
眠れる龍の覚醒：古代の武士道と次世代ブロックチェーンの融合、「KAMIRAI」がGameFiの定義を覆す
Jan 18, 2026 08:00: JST
|
|
|
New-look TGR-WRT launches landmark campaign on legendary rally
Jan 16, 2026 21:34 JST
|
|
|
Mitsubishi Corporation Announces Acquisition of Haynesville Shale Gas Business in Louisiana and Texas
Jan 16, 2026 21:12 JST
|
|
|
Celestion Brings Cutting-Edge Music Technology to Transform Hong Kong's Modern Listening Experience
Jan 16, 2026 19:44 HKT/SGT
|
|
|
Celestion以尖端音響科技革新香港家居聆聽體驗 先進多功能便攜音響系統Hometainer現正熱賣
Jan 16, 2026 19:44 HKT/SGT
|
|
|
日本株、米国株の自動売買取引を、スマホやPCで個人投資家でも簡単に行えるアプリ「Trade Stand（略称：トレスタ）」を大幅アップデート。TradingView自動売買をアプリ内で完結、日本株CFDにも対応。
Jan 16, 2026 17:00: JST
|
|
|
MHI Thermal Systems Expands Lineup of Building-Use Multi-Split Air-Conditioners for Overseas Markets
Jan 16, 2026 15:47 JST
|
|
|
三菱重工サーマルシステムズ、海外市場向けビル用マルチエアコンのラインアップを追加
Jan 16, 2026 13:30: JST
|
|
|
三菱商事、米国テキサス州・ルイジアナ州における ヘインズビルシェールガス事業への参画について
Jan 16, 2026 13:00: JST
|
|
|
三菱造船が開発した自動操船システム“SUPER BRIDGE-X”を搭載 世界初 旅客船における自動運転レベル4相当での商用運航開始
Jan 16, 2026 13:00: JST
|
|
|
興業銀行成功發行全市場首單自貿區主體「玉蘭債」
Jan 16, 2026 10:04 HKT/SGT
|
|
|
First three HKTDC trade fairs of 2026 draw some 82,000 international buyers
Jan 15, 2026 19:46 HKT/SGT
|
|
|
NEC Launches "NEC Composable Disaggregated Infrastructure Solution" for Distributed Computing Resources
Jan 15, 2026 17:00 JST
|
|
|
真正的賦能者——愛格法醫療於2026年歐洲放射學會議（ECR）展現影像創新風采
Jan 15, 2026 16:00 HKT/SGT
|
|
|
真正的赋能者——爱克发医疗在2026年欧洲放射学大会上展现影像创新力量
Jan 15, 2026 16:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
